LB
38
-7
PSA
66
3
CVS
45
-4
HRL
30
-5
IFF
56
-3
MMC
58
-2
BRK.B
42
-3
IR
72
-5
R
66
-4
PEP
47
-3
KEY
51
-3
NSC
62
-5
WU
12
-4
NWSA
47
-2
AVY
53
-9
TAP
45
-6
MCO
80
2
FRT
36
-2
QCOM
55
-4
GOOGL
56
2
LB
38
-7
PSA
66
3
CVS
45
-4
HRL
30
-5
IFF
56
-3
MMC
58
-2
BRK.B
42
-3
IR
72
-5
R
66
-4
PEP
47
-3
KEY
51
-3
NSC
62
-5
WU
12
-4
NWSA
47
-2
AVY
53
-9
TAP
45
-6
MCO
80
2
FRT
36
-2
QCOM
55
-4
GOOGL
56
2
Financhill
Back

SPDR® S&P Kensho Future Security ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
62

FITE
SPDR® S&P Kensho Future Security ETF

Last Price:
60.38
Seasonality Move:
1.71%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
62
SPDR® S&P Kensho Future Security ETF (FITE) is a Buy

Is SPDR® S&P Kensho Future Security ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Kensho Future Security ETF [FITE] share price is $60.48. The Score for FITE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • FITE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FITE Stock Price Chart

What is SPDR® S&P Kensho Future Security ETF's stock price today?

  • The SPDR® S&P Kensho Future Security ETF share price today is $60.48
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FITE is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

FITE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.29 Buy
Relative Strength Index (14 RSI): 60.66 Buy
Chaikin Money Flow: 1309 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.4 - 60.56) Buy
Bollinger Bands (100): (55.37 - 59.05) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

FITE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.3 Buy
20-day SMA: 59.32 Buy
50-day SMA: 58.65 Buy
200-day SMA: 56.28 Buy
8-day EMA: 59.51 Buy
20-day EMA: 59.17 Buy
50-day EMA: 58.52 Buy
200-day EMA: 55.74 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SPDR® S&P Kensho Future Security ETF Earnings Growth & FITE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SPDR® S&P Kensho Future Security ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):